NCT00733265View on ClinicalTrials.gov

Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Renal Impairment

Interventions

DRUG

AZD6140

single oral dose

Trial Locations (4)

Unknown

Research Site, Phoenix

Research Site, Anaheim

Research Site, Miami

Research Site, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY